Skip to main content
main-content

13-12-2017 | Image

Figure 1. Timeline of US (bottom) and European (top) approvals of biosimilar agents for the treatment of rheumatological conditions to date.

Figure 1. Timeline of US (bottom) and European (top) approvals of biosimilar agents for the treatment of rheumatological conditions to date.

Details of indications are given in table 2.

image credits